Nichi-Iko Pharmaceutical Co.,Ltd. 4541Short Interest
No institution currently reports a short position of 0.5% or more in Nichi-Iko Pharmaceutical Co.,Ltd. (4541). The last disclosure was on 2023-03-08 (Integrated Core Strategies (Asia) Pte. Ltd., 0.47%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
582 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.26% in total). It also excludes 10 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-29 |
|---|---|
| Latest disclosure | 2023-03-08 (Integrated Core Strategies (Asia) Pte. Ltd., 0.47%) |
| Reporting institutions | 15 firms (582 reports) |
| Peak estimated short interest | 7.88% (2022-06-02, 6 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- UBS AG
- GOLDMAN SACHS INTERNATIONAL
- Nomura International plc
- Integrated Core Strategies (Asia) Pte. Ltd.
- JPM Securities Japan Co Ltd.
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2018-07-23 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 442,800 shares | Ratio 0.72% | ▲0.11% | No report for 1+ year |
| 2019-10-02 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 354,605 shares | Ratio 0.54% | ▼0.16% | No report for 1+ year |
| 2017-12-28 | Credit Suisse Securities (Europe) Limited | Position 302,180 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2020-01-07 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 319,405 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2021-12-21 | MERRILL LYNCH INTERNATIONAL | Position 352,513 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2022-06-14 | JPM Securities Japan Co Ltd. | Position 343,174 shares | Ratio 0.48% | ▼0.04% | Below 0.5% |
| 2022-12-21 | GOLDMAN SACHS INTERNATIONAL | Position 346,274 shares | Ratio 0.48% | ▼0.14% | Below 0.5% |
| 2018-04-05 | Deutsche Bank Aktiengesellschaft, London | Position 287,408 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2023-03-08 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 341,102 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2022-11-11 | Nomura International plc | Position 320,800 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2022-09-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 303,656 shares | Ratio 0.42% | ▼0.26% | Below 0.5% |
| 2023-02-06 | UBS AG | Position 240,130 shares | Ratio 0.33% | ▼0.25% | Below 0.5% |
| 2021-04-02 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.50% | Closed |
| 2022-07-14 | Credit Suisse AG | Position 0 shares | Ratio 0.00% | ▼0.56% | Closed |
| 2022-09-05 | BNP Paribas Arbitrage SNC | Position 0 shares | Ratio 0.00% | ▼0.57% | Closed |
Disclosure History 582 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2023-03-08 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 341,102 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2023-02-27 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 427,202 shares | Ratio 0.59% | ▼0.10% | — |
| 2023-02-06 | UBS AG | Position 240,130 shares | Ratio 0.33% | ▼0.25% | Below 0.5% |
| 2023-01-31 | UBS AG | Position 420,330 shares | Ratio 0.58% | ▼0.09% | — |
| 2023-01-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 496,802 shares | Ratio 0.69% | ▼0.09% | — |
| 2023-01-26 | UBS AG | Position 482,030 shares | Ratio 0.67% | ▼0.10% | — |
| 2023-01-24 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 557,602 shares | Ratio 0.78% | ▼0.09% | — |
| 2023-01-20 | UBS AG | Position 555,530 shares | Ratio 0.77% | ▼0.10% | — |
| 2023-01-18 | UBS AG | Position 624,930 shares | Ratio 0.87% | ▲0.31% | — |
| 2023-01-17 | UBS AG | Position 406,430 shares | Ratio 0.56% | ▼0.04% | — |
| 2023-01-16 | UBS AG | Position 432,330 shares | Ratio 0.60% | ▲0.02% | — |
| 2023-01-16 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 628,102 shares | Ratio 0.87% | ▼0.19% | — |
| 2023-01-13 | UBS AG | Position 416,930 shares | Ratio 0.58% | ▲0.11% | — |
| 2023-01-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 758,402 shares | Ratio 1.06% | ▲0.64% | — |
| 2022-12-21 | GOLDMAN SACHS INTERNATIONAL | Position 346,274 shares | Ratio 0.48% | ▼0.14% | Below 0.5% |
| 2022-12-20 | GOLDMAN SACHS INTERNATIONAL | Position 445,274 shares | Ratio 0.62% | ▼0.24% | — |
| 2022-12-16 | GOLDMAN SACHS INTERNATIONAL | Position 619,574 shares | Ratio 0.86% | ▲0.37% | — |
| 2022-12-15 | GOLDMAN SACHS INTERNATIONAL | Position 356,574 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2022-12-13 | UBS AG | Position 30,530 shares | Ratio 0.04% | ▼1.01% | Below 0.5% |
| 2022-12-13 | GOLDMAN SACHS INTERNATIONAL | Position 380,074 shares | Ratio 0.53% | ▼0.10% | — |
| 2022-12-12 | UBS AG | Position 750,030 shares | Ratio 1.05% | ▼0.64% | — |
| 2022-12-09 | UBS AG | Position 1,207,830 shares | Ratio 1.69% | ▼0.02% | — |
| 2022-12-09 | GOLDMAN SACHS INTERNATIONAL | Position 455,174 shares | Ratio 0.63% | ▼0.12% | — |
| 2022-12-08 | UBS AG | Position 1,225,730 shares | Ratio 1.71% | ▼0.32% | — |
| 2022-12-02 | GOLDMAN SACHS INTERNATIONAL | Position 542,374 shares | Ratio 0.75% | ▼0.13% | — |
| 2022-12-01 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 294,202 shares | Ratio 0.41% | ▼0.30% | Below 0.5% |
| 2022-11-30 | UBS AG | Position 1,453,530 shares | Ratio 2.03% | ▲0.12% | — |
| 2022-11-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 508,502 shares | Ratio 0.71% | ▲0.09% | — |
| 2022-11-30 | GOLDMAN SACHS INTERNATIONAL | Position 628,774 shares | Ratio 0.88% | ▼0.10% | — |
| 2022-11-29 | UBS AG | Position 1,365,030 shares | Ratio 1.91% | ▲0.27% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |